Sequent Scientific Ltd Performance
Today's Low
115.20
Today's High
118.30
52 Wk Low
70.60
52 Wk High
155.50
Open
117.15
Traded Value (Cr)
4.18 Cr
Prev. Close
117.45
VWAP
116.57
Volume
3,09,603
Face Value
2
Sequent Scientific Ltd Fundamentals
Market Cap
₹ 2,898 Cr
P/E Ratio (TTM)
0.00
P/B Ratio
4.59
Debt to Equity
0.73
ROE
-8.61 %
EPS (TTM)
0.00
Dividend Yield
0.00%
Book Value
25.32
Sequent Scientific Ltd Financials
Sequent Scientific Ltd Financials
Resistance and Support
₹118.05
PIVOT
 Resistance | |
|---|---|
| First Resistance | ₹119.800 |
| Second Resistance | ₹121.700 |
| Third Resistance | ₹123.450 |
 Support | |
|---|---|
| First Resistance | ₹116.150 |
| Second Resistance | ₹114.400 |
| Third Resistance | ₹112.500 |
| RSI | 39.066 |
| MACD | -1.930 |
| ADX | 9.597 |
| CCI | -135.664 |
Delivery and Volume
About Sequent Scientific Ltd
Visistha Traders & Finance Ltd, has amalgamated PI Drugs & Pharmaceuticals Ltd with itself. The High court has sanctioned the Scheme of Amalgamation and the same was filed with ROC by the company on Nov 12, 2003.
Managing Director
N Rajaram
Founded
1985
NSE Symbol
SEQUENT
Sequent Scientific Ltd Management
| Name | Designation |
|---|---|
| Kausalya Santhanam | Non-Exec. & Independent Dir. |
| Sharat Narasapur | Joint Managing Director |
| Krunal Shah | Company Sec. & Compli. Officer |
| Neeraj Bharadwaj | Non-Exec & Non-Independent Dir |
| Gregory John Andrews | Non-Exec & Non-Independent Dir |
| Fabian Kausche | Non-Exec & Non-Independent Dir |
| Kamal K Sharma | Chairman & Independent Directo |
| Milind Sarwate | Non-Exec. & Independent Dir. |
| N Rajaram | Managing Director & CEO |
| Hari Babu Bodepudi | Director |
| PHILLIP TROTT | Company Sec. & Compli. Officer |
Sequent Scientific Ltd News
Sequent Scientific to conduct board meeting
On 15 May 2024
Sequent Scientific Jt. MD resigns
With effect from 30 April 2024
Sequent Scientific reports consolidated net profit of Rs 8.27 crore in the December 2023 quarter
Sales decline 12.24% to Rs 329.36 crore
Sequent Scientific announces board meeting date
On 13 February 2024
Sequent Scientific reports consolidated net loss of Rs 8.38 crore in the September 2023 quarter
Sales rise 2.48% to Rs 345.97 crore
Sequent Scientific announces board meeting date
On 6 November 2023
Sequent Scientific CFO Patri Venkat Raghavendra Rao resigns
Rao will continue in his current role till the close of business hours on 25 October 2023.
Sequent Scientific jumps after board approves API facility sale
Sequent Scientific rose 6.48% to Rs 93.60 after the company's board approved the sale or transfer of the API facility located in Tarapur, Maharashtra.
Sequent Scientific to conduct AGM
On 30 August 2023
Sequent Scientific reports consolidated net loss of Rs 34.85 crore in the June 2023 quarter
Sales decline 2.38% to Rs 333.21 crore